A Call to Action Against Persistent Lack of Transparency in Vaccine Pricing Practices During the COVID-19 Pandemic
References
- Sciacchitano S, Bartolazzi A. Transparency in Negotiation of European Union with Big Pharma on COVID-19 Vaccines Front. Public Health, 2021; 9: 647955. DOI: 10.3389/fpubh.2021.647955
- World Health Assembly 72. Improving the transparency of markets for medicines, vaccines, and other health products.
https://apps.who.int/iris/handle/10665/329301 Published May 28, 2019. Accessed June 25, 2021. - Mèdecin sans Frontières. Member States adopt the resolution on ‘Improving the transparency of markets for medicines, vaccines, and other health products’ at WHA today. Access Campaign.
https://msfaccess.org/member-states-adopt-resolution-improving-transparency-markets-medicines-vaccines-and-other-health . Published 28 May 2019. Accessed September 16, 2021. - Lee B, McGlone S. Pricing of new vaccines. Human Vaccines. 2010; 6(8): 619–626. DOI: 10.4161/hv.6.8.11563
- ACT-Accelerator. Strategic Plan & Budget. October 2021 to September 2022. World Health Organization 2021.
https://www.who.int/publications/m/item/act-accelerator-strategic-review Published October 8, 2021. Accessed November 10, 2021. - Fidler DP. Vaccine nationalism’s politics. Science. 2020; 369: 6505. DOI: 10.1126/science.abe2275
- Light DW, Lexchin J. The costs of coronavirus vaccines and their pricing. Journal of the Royal Society of Medicine. 2021; 114(11): 502–504. DOI: 10.1177/01410768211053006
- Dyer O. Covid-19: Countries are learning what others paid for vaccines. BMJ. 2021; 372: n281. DOI: 10.1136/bmj.n281
- Boseley S. Belgian minister tweets EU’s Covid vaccine price list to anger of manufacturers. The Guardian.
https://www.theguardian.com/world/2020/dec/18/belgian-minister-accidentally-tweets-eus-covid-vaccine-price-list Published December 18. 2020. Accessed December 10, 2021. - Murphy T. COVID-19 vaccine boosters could mean billions for drugmakers. AP News.
https://apnews.com/article/coronavirus-pandemic-business-science-health-coronavirus-vaccine-5305defac283ac5f352bc47fcb74c82b Published September 25, 2021. Accessed November 10, 2021 - Soreng KT, de Bengy Puyvallée A. Why does Pfizer deny the public investment in its Covid-19 vaccines? International Health Policies.
https://www.internationalhealthpolicies.org/featured-article/why-does-pfizer-deny-the-public-investment-in-its-covid-19-vaccine/ Published December 3, 2020. Accessed July 15, 2021. - Morgan SG, Bathula HS, Moon S. Pricing of pharmaceuticals is becoming a major challenge for health systems. BMJ. 2020; 368: 4627. DOI: 10.1136/bmj.l4627
- Tagmatarchi Storeng K, de Bengy Puyvallée A, Stein F. COVAX and the rise of the ‘super public private partnership’ for global health. Global Public Health; 2021. DOI: 10.1080/17441692.2021.1987502
- Davies M, Ruiz I, Langlois J, Furneaux R, Davies M. ‘Held to ransom’: Pfizer plays hardball in Covid-19 vaccine negotiations with Latin American countries. STAT.
https://www.statnews.com/2021/02/23/pfizer-plays-hardball-in-covid-19-vaccine-negotiations-in-latin-america/ Published February 23, 2021. Accessed December 6, 2021. - Hassan F. Don’t Let Drug Companies Create a System of Vaccine Apartheid. Foreign Policy.
https://foreignpolicy.com/2021/02/23/dont-let-drug-companies-create-a-system-of-vaccine-apartheid/ Published February 23, 2021. Accessed July 23, 2021. - Laing A, Garrison C. Amid scramble for COVID-19 vaccine, Latin America turns to Russia. Reuters.
https://www.reuters.com/business/healthcare-pharmaceuticals/amid-scramble-covid-19-vaccine-latin-america-turns-russia-2021-03-01/ Published March 1, 2021. Accessed May 4, 2021. - Moon S, Armstrong J, Hutler B, et al. Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability. The Lancet. 2021; 6736(21). DOI: 10.1016/S0140-6736(21)02344-8
- Gericke CA, Riesberg A, Busse R. Ethical issues in funding orphan drug research and development. Journal of Medical Ethics. 2005; 31: 164–168. DOI: 10.1136/jme.2003.007138
- Morel Ch M, Lindahl O, Harbarth S, et al. Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus. The Journal of Antibiotics. 2020; 73: 421–428. DOI: 10.1038/s41429-020-0300-y
- Wouters O. Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999–2018. JAMA Intern Med. 2020; 180(5): 688–697. DOI: 10.1001/jamainternmed.2020.0146
- Médecin Sans Frontières. Spotlight on: TRIPS, TRIPS Plus, and Doha. Access Campaign.
https://msfaccess.org/spotlight-trips-trips-plus-and-doha Accessed July 12, 2021 - Arguedas-Ramírez G.
COVID-19, Justicia distributiva, propiedad intelectual y geopolítica: Una contextualización de la gestión del Gobierno de Costa Rica ante la OMS . In: Ortiz-Millán, Medina-Arellano, (eds.), COVID-19 y bioética. 1st ed. México, DF: UNAM. 2021; 415–433. DOI: 10.22201/iij.9786073048880e.2021.c22 - Editorial. Time is running out for COVID vaccine patent waivers. Nature. 2022; 603: 764.
https://www.nature.com/articles/d41586-022-00878-x - Robbins R. W.T.O. countries agree to a limited relaxing of patent protections on coronavirus vaccines. The New York.
https://www.nytimes.com/2022/06/17/business/wto-covid-vaccine-patent.html Published June 17, 2022. Accessed August 20, 2022. - Zard M, Lau LS, Bowser DM, et al. Leave no one behind: ensuring access to COVID-19 vaccines for refugee and displaced populations. Nature Medicine. 2021; 27: 747–749. DOI: 10.1038/s41591-021-01328-3
- de Bolle M. COVAX is failing to halt the COVID-19 pandemic: Here’s why, and how to fix it. The Conversation.
https://theconversation.com/covax-is-failing-to-halt-the-covid-19-pandemic-heres-why-and-how-to-fix-it-162146 Published June 8, 2021. Accessed September 12, 2021. - WHO Working Group on Strengthening Who Preparedness and Response to Health Emergencies.
Zero draft report to the Seventy-fifth World Health Assembly . 3 May 2022. WHO.https://apps.who.int/gb/wgpr/pdf_files/wgpr9/A_WGPR9_3-en.pdf . - Allen A. Kaiser Health News. Facing price controls, pharma industry cranks up heat on Congress. CNN.
https://edition.cnn.com/2022/08/12/health/pharma-spending-bill-khn/index.html Published August 13, 2022. Accessed August 20, 2022. - Spitz J, Wickham M. Pharmaceutical High Profits: The Value of R&D, or Oligopolistic Rents? The American Journal of Economics and Sociology. 2012; 71(1): 1–36. DOI: 10.1111/j.1536-7150.2011.00820.x
DOI: https://doi.org/10.5334/aogh.3898 | Journal eISSN: 2214-9996
Language: English
Submitted on: Jul 9, 2022
Accepted on: Sep 16, 2022
Published on: Oct 11, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2022 Gabriela Arguedas-Ramírez, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.